Cell Host & Microbe
Scope & Guideline
Exploring the Frontiers of Infectious Disease Research
Introduction
Aims and Scopes
- Host-Microbe Interactions:
The journal emphasizes research on how microorganisms interact with their hosts, influencing health and disease outcomes. - Microbial Ecology:
Studies that explore the ecology of microbial communities, including their composition, dynamics, and roles in various environments, particularly the human gut. - Immunology and Infection:
Research that investigates the immune responses to microbial infections, including viral, bacterial, and fungal pathogens, and how these responses can be modulated. - Therapeutic Applications:
The journal publishes studies on the development of microbial-based therapies, including probiotics, prebiotics, and engineered microbes for treating diseases. - Technological Advances in Microbiology:
Articles that focus on innovative methodologies and technologies, such as CRISPR, genomics, and bioinformatics, that enhance our understanding of host-microbe interactions. - Cross-Kingdom Interactions:
Research that investigates interactions between different kingdoms of life, such as fungi, bacteria, and viruses, and their collective impact on host health.
Trending and Emerging
- Microbiome and Mental Health:
There is a notable increase in research exploring the gut-brain axis and how gut microbiota influence mental health conditions, suggesting a significant interplay between microbial composition and neurological outcomes. - Metabolomics in Microbial Research:
The integration of metabolomics to study microbial interactions and their effects on host metabolism is on the rise, revealing insights into how microbial metabolites influence health. - Immunotherapy and Microbiome Interactions:
Emerging studies are focusing on how the microbiome affects the efficacy of immunotherapies in cancer treatment, indicating a critical role for microbial communities in shaping therapeutic outcomes. - Synthetic Microbiomes and Engineering:
Research on engineered microbial communities and synthetic biology approaches is expanding, aiming to design microbes for specific therapeutic purposes. - Antimicrobial Resistance Studies:
As antibiotic resistance becomes a pressing global issue, research focusing on understanding and combating antimicrobial resistance through microbiome manipulation is increasingly prevalent. - Viral Ecology and Evolution:
The exploration of viral communities within the microbiome, including their evolutionary dynamics and interactions with bacterial hosts, is gaining traction, reflecting a broader interest in viral roles in health and disease.
Declining or Waning
- Plant-Microbe Interactions:
While still relevant, research specifically focused on plant-microbe interactions has diminished as more emphasis has shifted towards human microbiome studies and their implications for health. - Traditional Antibiotic Research:
Studies primarily centered on the mechanisms of traditional antibiotics are less frequent, likely due to the growing interest in alternative therapies such as phage therapy and microbial consortia. - Single Organism Studies:
Research focusing on individual microbial species without considering the broader context of microbial communities has decreased as the field moves towards a more holistic understanding of microbiomes. - Basic Virology:
While virology remains important, basic studies on viral mechanisms without direct implications for host interactions or therapeutic applications are becoming less prominent in favor of studies with translational potential.
Similar Journals
Microbiology Spectrum
Advancing microbiological research for a healthier world.Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.
Microbial Cell
Fostering collaboration in microbial research.Microbial Cell is a distinguished open-access journal published by SHARED SCIENCE PUBLISHERS OG, focusing on the dynamic fields of microbiology, biochemistry, and molecular biology. Since its establishment in 2014, Microbial Cell has been at the forefront of disseminating cutting-edge research essential for advancing our understanding of microbial functions and interactions. With a commendable impact factor and ranking in the top quartiles (Q1 and Q2) across several categories, including Applied Microbiology and Biotechnology and Parasitology, this journal serves as an invaluable resource for researchers, professionals, and students alike. It features a comprehensive scope that encompasses the latest findings in genetics, cell biology, and virology, facilitating the academic community's access to high-quality peer-reviewed work. Microbial Cell not only contributes to advancing microbial sciences but also fosters an inclusive platform for knowledge sharing and collaboration in the scientific community.
TRENDS IN MICROBIOLOGY
Uncovering Trends that Transform Microbial UnderstandingTRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.
CURRENT OPINION IN MICROBIOLOGY
Shaping the future of microbiology with expert insights.CURRENT OPINION IN MICROBIOLOGY is a prestigious academic journal published by CURRENT BIOLOGY LTD, dedicated to advancing the field of microbiology through timely and insightful reviews. With an ISSN of 1369-5274 and an e-ISSN of 1879-0364, this journal has established itself as a leading source of knowledge in various subfields, consistently achieving a Q1 ranking in Infectious Diseases and Microbiology for 2023. Operating from the United Kingdom, CURRENT OPINION IN MICROBIOLOGY serves a critical role for researchers, clinicians, and students alike by disseminating groundbreaking findings and fostering discussions that shape the future of microbiological research. The journal's rigorous selection process ensures that only high-quality articles are published, reflecting its strong impact factor and high percentile rankings across relevant Scopus categories. Although it does not follow an open-access model, its comprehensive scope and valuable contributions to the medical and scientific community underscore its importance as an essential resource for advancing our understanding of microbial sciences.
CRITICAL REVIEWS IN MICROBIOLOGY
Illuminating Trends in Microbiology ResearchCRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.
ANAEROBE
Advancing Knowledge in Microbial InteractionsANAEROBE is a highly regarded scholarly journal published by Elsevier Science Ltd, dedicated to advancing the study of anaerobic microorganisms and their roles in infectious diseases, microbiology, and various clinical applications. With an ISSN of 1075-9964 and an E-ISSN of 1095-8274, this journal has established itself as a pivotal resource for researchers and professionals interested in the unique aspects of anaerobic biology since its inception in 1995. Ranking in the Q2 category in both Infectious Diseases and Microbiology, it stands out for its commitment to publishing high-quality research that reflects the evolving complexities of microbial interactions in health and disease. Although the journal currently does not offer Open Access options, its impact is notable, with the 2023 Scopus rankings reflecting a practice of excellence—ranked #137/344 in Infectious Diseases and #96/182 in Microbiology. As a vital forum for scholarly exchange, ANAEROBE serves as an essential platform for scientists seeking to explore the depths of anaerobic studies, shaping future discoveries and clinical advancements.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
Exploring the frontiers of microbial interactions.ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Driving innovation in the study of microbes and their immune interactions.Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.
MicrobiologyOpen
Advancing microbiological research for a global audience.MicrobiologyOpen is a prestigious, open access journal published by WILEY, dedicated to advancing the field of microbiology. Since its inception in 2012, this journal has firmly established itself as a significant platform for researchers, professionals, and students alike, facilitating the dissemination of high-quality research findings across a wide range of microbiological disciplines. With an impressive impact factor and a ranking in the 76th percentile of Scopus for immunology and microbiology, MicrobiologyOpen offers a robust forum for innovative studies, reviews, and compelling insights that push the boundaries of scientific understanding. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, fostering collaboration and knowledge-sharing. As it continues to evolve until 2024, MicrobiologyOpen remains pivotal for anyone looking to stay at the forefront of microbiological research.
APMIS
Pioneering Research for the Future of Medical ScienceAPMIS is a distinguished academic journal published by WILEY that serves as a vital resource for researchers and practitioners in the fields of Immunology, Allergy, Microbiology, and Pathology. Established in 1988 and continuing its mission through 2024, this journal facilitates the dissemination of high-quality research findings, contributing to the intersection of multiple disciplines within the medical sciences. With an ISSN of 0903-4641 and an E-ISSN of 1600-0463, APMIS is categorized in 2023's Q2 and Q3 quartiles across various domains, reflecting its significant impact, with rankings such as #50/208 in Pathology and Forensic Medicine and #121/233 in Immunology and Allergy. Although it currently does not offer open access options, the journal’s rigorous peer-review process ensures that published articles maintain the highest standards of scholarship. With its focus on innovative research, APMIS continues to occupy a pivotal role for those seeking to advance their expertise and contribute to scientific dialogue in these essential fields.